A combined MRI-PSAD risk stratification system for prioritizing prostate biopsies
CONCLUSIONS: Our findings suggest that a three-tier risk classification system based on mpMRI and PSAD can identify patients at high-risk for CSPC who may benefit from earlier biopsy.PMID:38401259
Source: Canadian Journal of Urology - Category: Urology & Nephrology Authors: Noam Bar-Yaakov Ziv Savin Ibrahim Fahoum Sophie Barnes Yuval Bar-Yosef Ofer Yossepowitch Gal Keren-Paz Roy Mano Source Type: research
More News: Canada Health | Cancer | Cancer & Oncology | Prostate Cancer | Study | Urology & Nephrology